Free Trial

Q3 Earnings Estimate for kneat.com Issued By Stifel Canada

kneat.com logo with Medical background

Key Points

  • Stifel Canada has decreased their Q3 2025 earnings estimate for kneat.com to ($0.06) per share, down from the previous estimate of ($0.03).
  • Raymond James Financial has lowered its target price for kneat.com from C$7.50 to C$7.00 while maintaining an "outperform" rating.
  • The current full-year consensus estimate for kneat.com earnings is ($0.12) per share, with projected Q4 2025 earnings at ($0.04) EPS.
  • Looking to export and analyze kneat.com data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

kneat.com, inc. (TSE:KSI - Free Report) - Equities research analysts at Stifel Canada lowered their Q3 2025 earnings per share (EPS) estimates for shares of kneat.com in a research note issued to investors on Wednesday, August 6th. Stifel Canada analyst J. Keywood now anticipates that the company will post earnings of ($0.06) per share for the quarter, down from their previous forecast of ($0.03). The consensus estimate for kneat.com's current full-year earnings is ($0.12) per share. Stifel Canada also issued estimates for kneat.com's Q4 2025 earnings at ($0.04) EPS, FY2025 earnings at ($0.18) EPS and FY2026 earnings at ($0.17) EPS.

Separately, Raymond James Financial cut their target price on kneat.com from C$7.50 to C$7.00 and set an "outperform" rating on the stock in a research report on Wednesday, August 6th.

Check Out Our Latest Stock Analysis on KSI

kneat.com Price Performance

Shares of kneat.com stock traded down C$0.06 during trading on Monday, hitting C$5.71. The stock had a trading volume of 20,466 shares, compared to its average volume of 93,498. The business has a fifty day moving average of C$5.99 and a two-hundred day moving average of C$6.25. The firm has a market cap of C$533.89 million, a P/E ratio of -61.68, a PEG ratio of 597.67 and a beta of 1.08. The company has a debt-to-equity ratio of 85.50, a current ratio of 1.43 and a quick ratio of 1.50. kneat.com has a fifty-two week low of C$4.50 and a fifty-two week high of C$7.25.

About kneat.com

(Get Free Report)

kneat.com Inc is in the business of developing and marketing a software application for modelling regulated data-intensive processes for regulated industries, focusing on the life sciences industry. The company has developed Kneat Gx solution which provides management real-time visibility and control and increases product, quality, and compliance.

Featured Articles

Earnings History and Estimates for kneat.com (TSE:KSI)

Should You Invest $1,000 in kneat.com Right Now?

Before you consider kneat.com, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and kneat.com wasn't on the list.

While kneat.com currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

September Slowdown: 3 Stocks to Buy When the Pullback Comes
3 Overlooked Stocks Riding the AI Data Center Boom
3 Growth Stock Winners to Watch And 3 to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines